Navigation Links
Angiotech to Establish Separate Operating and Royalty Businesses
Date:7/7/2008

ipation in API for our shareholders," said Dr. William Hunter, President and Chief Executive Officer of Angiotech. "We are excited to work with our new partners at Ares and New Leaf, who offer us considerable capital resources and business experience, to execute our strategy of developing drug-device combinations, locally deliverable drugs, or other novel technologies that improve the outcomes of surgical or other medical interventions."

"This transaction offers Angiotech the opportunity for meaningful reduction of debt and interest expense, and allows us to raise a total amount of proceeds greater than would have been reasonably achievable through the consolidated company's capital alternatives," said Thomas Bailey, Chief Financial Officer of Angiotech. "After considering a wide range of strategic alternatives with the assistance of our advisors, our Board determined that this transaction establishes a more flexible capital structure to support our various business and product development initiatives."

"We are pleased, together with New Leaf, to have the opportunity to work with Angiotech to establish and capitalize API," said Bennett Rosenthal, Senior Partner of Ares Management. "The combination of our firms' significant capital resources, financial expertise and health care investing experience make us ideal partners for API. We are all tremendously excited about the market potential and growth trajectory of the company's various product opportunities."

"New Leaf and Ares believe that Angiotech has a very attractive portfolio of marketed products and pipeline programs, and that this transaction puts the Company in the best position to support these assets with the investments needed to maximize their long term potential," said Ron Hunt, Managing Director of New Leaf Venture Partners, LLC.

Transaction Highlights

- Raises substantial proceeds in equity-linked security targeted to

reduce cash pay debt. The propos
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
2. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
3. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
4. Angiotech to participate in UBS Global Life Sciences Conference
5. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
6. Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
7. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
8. Angiotech to participate in Bank of America 2007 Credit Conference
9. Angiotech to participate in RBC 2007 Healthcare Conference
10. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
11. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 2015 /PRNewswire/ - Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced ... Resverlogix have approved the resolutions relating to: (i) ... 5,600,000 units at a price of $2.67 per ... comprised of one common share and 0.075358 common ... CAD$15 million; and (ii) the amendment to Resverlogix,s ...
(Date:6/30/2015)... , June 30, 2015  NASA astronaut Kjell Lindgren ... month on his first mission to the International Space ... 8 to 9 a.m. EDT Tuesday, July 7. ... Star City, Russia . The interviews will ... Television highlighting his mission training. To schedule an ...
(Date:6/30/2015)... Americord Registry, one of the fastest growing cord blood banks ... at Kirkland & Ellis LLP, as the newest member of ...   "We are thrilled about Andrew Horne,s ... , CEO of Americord. "He brings a wealth of knowledge ... growth and vision." Andrew Horne is ...
(Date:6/30/2015)... ... 30, 2015 , ... With its latest polyacrylonitrile (PAN) membrane, ... faster flow rates in comparison to nylon or polyethersulfone (PES). Its unique ... easy liquid flow while trapping particulates as small as 0.2 micron in width. ...
Breaking Biology Technology:Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3NASA Astronaut Preps for First Space Station Mission, Available for Media Interviews 2Americord Registry Announces Andrew Horne as Advisory Board Member 2New Nanofiber Membrane Provides Fast, Efficient Filtration 2
... 2 Vermillion, Inc. (OTC Bulletin Board: VRML) today ... reorganization relief under Chapter 11 of the United States ... the District of Delaware ("Bankruptcy Court") in Wilmington, Delaware. ... as it focuses on obtaining regulatory clearance respecting the ...
... 2 Shire plc (LSE: SHP,NASDAQ: SHPGY ... the U.S. District,Court for the Southern District of New ... of Shire,s patents: U.S. Patent No.,5,968,976 (",976 Patent"); and ... The lawsuit was filed in response to ...
... test for detection of methicillin-resistant Staphylococcus aureus for better ... that its new LightCycler(R) test for the detection of ... with the CE Mark, allowing it to be sold ... MRSA Advanced Test is a qualitative in vitro ...
Cached Biology Technology:Vermillion, Inc. Files a Voluntary Petition for Reorganization Relief Under Chapter 11 of the United States Bankruptcy Code 2Vermillion, Inc. Files a Voluntary Petition for Reorganization Relief Under Chapter 11 of the United States Bankruptcy Code 3Vermillion, Inc. Files a Voluntary Petition for Reorganization Relief Under Chapter 11 of the United States Bankruptcy Code 4Vermillion, Inc. Files a Voluntary Petition for Reorganization Relief Under Chapter 11 of the United States Bankruptcy Code 5Shire Files Lawsuit Against Natco Pharma for Infringement of FOSRENOL(R) (lanthanum carbonate) Patents 2Roche to Introduce New LightCycler(R) MRSA Advanced Test in the EU 2Roche to Introduce New LightCycler(R) MRSA Advanced Test in the EU 3Roche to Introduce New LightCycler(R) MRSA Advanced Test in the EU 4
(Date:6/16/2015)... 16, 2015 /CNW Telbec/ - handyem Inc. and ... the incorporation of handyem,s HPC-150 portable flow cytometer ... Mo-POD™. This unprecedented model of mobile laboratory platform ... the Pennsylvania Convention Center, ... th to 18 th 2015.  By ...
(Date:6/16/2015)... June 16, 2015 Fingerprint Cards (FPC) ... that it will amount to at least 340 MSEK to ... the rapid increase in market growth and orders received the ... guidance that revenue for 2015 will exceed 1,500 MSEK to ... approximately 2,200 MSEK. Due to receipt of orders ...
(Date:6/15/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... mobile commerce market, announces that its leading payment security technology, ... Digital Experience! @ NYC June 18th. Digital Experience! ... innovation in technology to over 300 of the top media ... Metropolitan Pavilion in New York City ...
Breaking Biology News(10 mins):handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 2Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 3
... who dealt with the strain of a hurricane or major ... were at elevated risk for abnormal health conditions at birth, ... that offers new insights into the effects of stress on ... meteorological information to identify children born in the state between ...
... the Hollings Marine Laboratory (HML) and four partner organizations ... perfluoroalkyl compounds (PFCs) in five different endangered species of ... been conducted on turtles, the levels of the compounds ... to cause adverse health effects in other animals. ...
... to the U.S. for sale through plant nurseries, are ... legislation restricts the introduction of certain species, the procedures ... list are haphazard and out of date. ... analysis, researchers at the University of Georgia Odum School ...
Cached Biology News:Study offers new insights into the effects of stress on pregnancy 2Study offers new insights into the effects of stress on pregnancy 3Study offers new insights into the effects of stress on pregnancy 4Pollutants could pose health risks for 5 sea turtle species 2Pollutants could pose health risks for 5 sea turtle species 3Screening horticultural imports: New models assess plant risk through better analysis 2Screening horticultural imports: New models assess plant risk through better analysis 3
...
Mouse monoclonal antibody to UGT2B10 - UDP glucuronosyltransferase 2 family, polypeptide B10...
Mouse polyclonal antibody raised against a partial recombinant COASY. NCBI Entrez Gene ID = 80347...
... 2-D starter kit is intended for first-time users ... strips. The kit includes a protein sample and ... second-dimension gels six 17 cm, ten 11 cm, ... IPG strips and precast SDS-PAGE gels and gels ...
Biology Products: